Does it devalue novelty? Eg where you publish?

How is a preprint structured? Is there a criteria for how it should be presented?

Is the understanding of the use of the preprint evolving?
Could it be a fake news problem?
Number of authors - suspicious if see one only.
Clin sci - medrxiv just launched, expect a more stringent process, journals not yet ready for it
Is there a use of multiple servers?
Can you publish negative findings?
Is there a standard for preprints? ASAPbio are trying to establish standard. Matters to funders as need to know directory of reputable preprint servers.
Cell press sneak peek preview - bad behaviour, a (free) subscription journal club on mendeley. Do funders want to know if preprints are open.
Advantage of preprints = rapid feedback but who reads them?
Word of mouth recommendations
There are subject lists by email
Twitter is huge
Impact of preprints - data of downloads as preprints versus impact of paper yet
PLoS genetics know have preprint editors, turns it into marketplace
You could tweet with a good video, etc versus asking others to tweet
OA nature of preprints, why pay to publish OA?